| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |